472 related articles for article (PubMed ID: 21949883)
1. Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.
Santis G; Angell R; Nickless G; Quinn A; Herbert A; Cane P; Spicer J; Breen R; McLean E; Tobal K
PLoS One; 2011; 6(9):e25191. PubMed ID: 21949883
[TBL] [Abstract][Full Text] [Related]
2. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.
Folch E; Yamaguchi N; VanderLaan PA; Kocher ON; Boucher DH; Goldstein MA; Huberman MS; Kent MS; Gangadharan SP; Costa DB; Majid A
J Thorac Oncol; 2013 Nov; 8(11):1438-1444. PubMed ID: 24128714
[TBL] [Abstract][Full Text] [Related]
3. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
[TBL] [Abstract][Full Text] [Related]
4. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.
Schuurbiers OC; Looijen-Salamon MG; Ligtenberg MJ; van der Heijden HF
J Thorac Oncol; 2010 Oct; 5(10):1664-7. PubMed ID: 20871266
[TBL] [Abstract][Full Text] [Related]
5. Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.
Lewandowska MA; Jóźwicki W; Jochymski C; Kowalewski J
Oncol Rep; 2013 Sep; 30(3):1045-52. PubMed ID: 23817662
[TBL] [Abstract][Full Text] [Related]
6. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
van Eijk R; Licht J; Schrumpf M; Talebian Yazdi M; Ruano D; Forte GI; Nederlof PM; Veselic M; Rabe KF; Annema JT; Smit V; Morreau H; van Wezel T
PLoS One; 2011 Mar; 6(3):e17791. PubMed ID: 21408138
[TBL] [Abstract][Full Text] [Related]
7. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
8. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V
Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724
[TBL] [Abstract][Full Text] [Related]
9. Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.
Oezkan F; Herold T; Darwiche K; Eberhardt WEE; Worm K; Christoph DC; Wiesweg M; Freitag L; Schmid KW; Theegarten D; Hager T; Koenig MJ; He K; Taube C; Schuler M; Breitenbuecher F
Clin Lung Cancer; 2018 Nov; 19(6):e879-e884. PubMed ID: 30206042
[TBL] [Abstract][Full Text] [Related]
10. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration.
Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Kubo R; Mohammed S; Miyagi Y; Matsukuma S; Sekine Y; Fujisawa T
Chest; 2007 Aug; 132(2):597-602. PubMed ID: 17573511
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration].
Boulanger S; Delattre C; Descarpentries C; Escande F; Bouchindhomme B; Copin MC; Dhalluin X; Scherpereel A; Ramon PP; Cortot A; Fournier C
Rev Mal Respir; 2013 May; 30(5):351-6. PubMed ID: 23746811
[TBL] [Abstract][Full Text] [Related]
12. Genotyping non-small cell lung cancer (NSCLC) in Latin America.
Arrieta O; Cardona AF; Federico Bramuglia G; Gallo A; Campos-Parra AD; Serrano S; Castro M; Avilés A; Amorin E; Kirchuk R; Cuello M; Borbolla J; Riemersma O; Becerra H; Rosell R;
J Thorac Oncol; 2011 Nov; 6(11):1955-9. PubMed ID: 22005474
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Gao J; Chen JQ; Zhang L; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of endobronchial ultrasound (EBUS)-derived cytological fine needle aspirates from hilar and mediastinal lymph nodes in non-small cell lung cancer.
Lee R; Cousins DJ; Ortiz-Zapater E; Breen R; McLean E; Santis G
Cytopathology; 2013 Dec; 24(6):351-5. PubMed ID: 23216930
[TBL] [Abstract][Full Text] [Related]
16. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL
J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922
[TBL] [Abstract][Full Text] [Related]
17. Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.
Lee K; Um SW; Jeong BH; Yang JW; Choi YL; Han J; Kim H; Kwon OJ
Intern Med; 2016; 55(21):3105-3111. PubMed ID: 27803402
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer.
Centeno C; Serra Mitja P; Avila M; Carcereny E; Muñoz-Mármol AM; Moran T; Castellà E; Sanz-Santos J; García Olivé I; Ramirez Serrano JL; Rosell Gratacos A; Andreo García F
Pulmonology; 2022; 28(1):28-33. PubMed ID: 32507497
[TBL] [Abstract][Full Text] [Related]
20. Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice.
Sun L; Zhang Q; Luan H; Zhan Z; Wang C; Sun B
J Exp Clin Cancer Res; 2011 Mar; 30(1):30. PubMed ID: 21414214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
